Developing a nanoparticle test for prostate cancer scoring

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Huo, Qun ^a   Litherland, Sally A ^b   Sullivan, Shannon ^a   Hallquist, Hillari ^a   Decker, David A ^b   Rivera Ramirez, Inoel ^b  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

Biomarker; Cancer aggressiveness; Molecular diagnostics; Nanoparticle; Prostate cancer

Indexed keywords

CITRIC ACID; GOLD NANOPARTICLE; IMMUNOGLOBULIN G; DIAGNOSTIC AGENT; GOLD; METAL NANOPARTICLE; TISSUE EXTRACT; TUMOR PROTEIN;

ADSORPTION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIGHT SCATTERING; NANOPARTICLE TEST; PARTICLE SIZE; PREDICTION; PROCESS DEVELOPMENT; PROSTATE CANCER; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SERUM; BIOLOGICAL MODEL; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PROSTATE TUMOR; SOLUTION AND SOLUBILITY;

ADSORPTION; GOLD; HUMANS; IMMUNOGLOBULIN G; MALE; METAL NANOPARTICLES; MODELS, BIOLOGICAL; NANOTECHNOLOGY; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; SERUM; SOLUTIONS; TISSUE EXTRACTS;

EID: 84857945391     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-44     Document Type: Article

References (16)

1. Draisma G, Etzioni R, Tsodikow A, Mariotto A, Wever E, Gulati R, Feuer E, deKoning H. Lead time and overdiagnoses in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Int 2009, 101:374-383.
2. Dubbelman YD, Dohle GR, Schröder FH. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur. Urology 2006, 50:711-720.
3. Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou J, Chen H, Huo Q. A One-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc 2008, 130:2780-2782. 10.1021/ja711298b, 18257576.
4. Jans H, Liu X, Austin L, Maes G, Huo Q. Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding study. Anal Chem 2009, 81:9425-9432. 10.1021/ac901822w, 19803497.
5. Bogdanovic J, Colon J, Baker C, Huo Q. A label-free nanoparticle aggregation assay for protein complex/aggregate detection and analysis. Anal Biochem 2010, 45:96-102.
6. Huo Q. Protein complexes/aggregates as potential cancer biomarkers revealed by a nanoparticle aggregation assay. Colloids Surfaces B 2010, 78:259-265.
7. Jaganathan S, Bogdanovic J, Huo Q, Turkson J. A functional nuclear epidermal growth factor receptor, Src and Stat3 heteromeric complex in pancreatic cancer cells. PLoS ONE 2011, 6:e19605. (Open Access), 10.1371/journal.pone.0019605, 3088706, 21573184.
8. Huo Q, Cordero A, Bogdanovic J, Colon J, Baker CH, Goodison S, Pensky M. A facile nanoparticle immunoassay for cancer biomarker discovery. J Nanobiotechnology 2011, 9:20. (Open Access), 10.1186/1477-3155-9-20, 3127990, 21605409.
9. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine NBM 2009, 5:106-117.
10. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci 2008, 105:14265-14270. 10.1073/pnas.0805135105, 2567179, 18809927.
11. Calzolai L, Franchini F, Gilliland D, Rossi F. Protein-nanoparticle interaction: identification of the ubiquitin-gold nanoparticle interaction site. Nano Lett 2010, 10:3101-3105. 10.1021/nl101746v, 20698623.
12. Mazaheri Y, Hricak H, Fine SW, Akin O, Shukla-Dave A, Ishill NM, Moskowitz CS, Grater JE, Reuter VE, Zakian KL, Touijer KA, Koutcher JA. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009, 252:449-457. 10.1148/radiol.2523081423, 2753786, 19703883.
13. Hermanson GT. Bioconjugate Techniques, 2nd ed.; Pierce Biotechnology. 2008, Chapter 24. Thermo Fisher Scientific: Rockford, IL.
14. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111. 10.1038/35074122, 11323675.
15. Khatami M. "Yin" and "Yang" in inflammation: duality in innate immune cell function and tumorigenesis. Exp Opin Biol Ther 2008, 8:1461-1472.
16. Brändlein S, Pohle T, Ruoff N, Wozniak E, Müller-Hermelink HK, Vollmers HP. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Res 2003, 63:7995-8005.